---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-182843"
form_type: "8-K"
ticker: "XAGE"
cik: "0001842939"
company_name: "Longevity Health Holdings, Inc."
filed_at: "2023-07-06T23:59:59+00:00"
generated_at: "2026-06-13T12:09:27.776959+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Alpha Healthcare provides Carmell merger update; LOI for commercial stage allograft company with $50M revenue

## Summary
- Shareholder vote for Carmell merger scheduled July 11, 2023; redemption deadline July 7.
- Non-binding LOI to acquire a commercial stage allograft company with ~$50M TTM revenue and ~$5M EBITDA.
- Deal terms: $65M initial equity ($8M cash + $57M stock) plus up to $75M milestone payments (12% cash, 88% stock); 12-month lockup.
- Carmell's pipeline: Phase 2 tibia fracture trial (Fast Track), FDA agreed HEAL II start; foot/ankle fusion program.
- Post-merger ticker CTCX; plan to build leading player in aesthetics and orthopedics through roll-ups.

## SEC filing metadata
- accession: 0001193125-23-182843
- form_type: 8-K
- ticker: XAGE
- cik: 0001842939
- company_name: Longevity Health Holdings, Inc.
- filed_at: 2023-07-06T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1842939/000119312523182843/0001193125-23-182843-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1842939/000119312523182843/d492441d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-182843
- JSON: https://secwatch.observer/filing/0001193125-23-182843.json
- Plain text: https://secwatch.observer/filing/0001193125-23-182843.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.